CITEQ B V has a total of 13 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals and basic materials chemistry are ARJUNA NATURAL EXTRACTS LTD, NAPO PHARMACEUTICALS INC and BOSCH H WILLIAM.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | Netherlands | 2 | |
#5 | Australia | 1 | |
#6 | United States | 1 | |
#7 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Basic materials chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Preservation of human bodies |
# | Name | Total Patents |
---|---|---|
#1 | Henning Robert Henk | 6 |
#2 | Roks Antonius Jacobus Marinus | 6 |
#3 | Van Der Graaf Adrianus Cornelis | 5 |
#4 | Hesse Laura | 4 |
#5 | Van Gilst Wiekert Hendrikus | 4 |
#6 | Van Der Graaf Adrianus Corneli | 4 |
#7 | Nawijn Martijn Christiaan | 4 |
#8 | Euverink Gerrit Jan Willem | 4 |
#9 | Gilst Wiekert Hendrikus Van | 2 |
#10 | Graaf Andrianus Cornelis Van D | 1 |
Publication | Filing date | Title |
---|---|---|
NL2021893B1 | Biological pest control agent | |
NL2014882A | Allergy-specific immunotherapy compositions for use in the treatment of house-dust mite allergy. | |
EP1348440A1 | Use of angiotensin 1-7 for enhancing cardiac function |